pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·6h ago·2 min read
save

STAT+: Bracing for another Fauci hearing

Plus: Democrats take on Trump over IVF, and Trump's White House releases a new science funding blueprint.

Jul 28, 2026·read at STAT ↗RegulatoryNeutral

STAT PlusNewsletterD.C. Diagnosis Bracing for another Fauci hearing You’re reading STAT’s D.C. Diagnosis newsletter Manage alerts for this article Email this article Share this article By John WilkersonJuly 28, 2026 Washington Correspondent John Wilkerson[email protected]John writes about the politics of health care, and he is the author of the twice-weekly D.C.

Diagnosis newsletter. You can reach John on Signal at John_Wilkerson.07. You’re reading the web edition of D.C.

Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays. Denver is holding a Potato Palooza to give away a surfeit of spuds.

Send news tips and tater salad tricks to [email protected] or John_Wilkerson.07 on Signal. Also, join STAT’s Isabella Cueto and Lev Facher tomorrow at 1 p.m. EDT for Office Hours, a live Q&A about the latest in their series on the U.S.

alcohol epidemic.Advertisement Fauci subpoenaed to testify before Senate panel Anthony Fauci is scheduled to testify again tomorrow before Congress, this time at the Senate homeland security committee. STAT+ Exclusive Story Already have an account? Log in This article is exclusive to STAT+ subscribers Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in Monthly $39 Totals $468 per year $39/month Get Started Totals $468 per year Starter $30 for 3 months, then $399/year $30 for 3 months Get Started Then $399/year Annual $399 Save 15% $399/year Get Started Save 15% 11+ Users Custom Savings start at 25%! Request A Quote Request A Quote Savings start at 25%!

2-10 Users $300 Annually per user $300/year Get Started $300 Annually per user View All Plans To read the rest of this story subscribe to STAT+. Subscribe Log In Congress, Health insurance, Policy, reproductive health, STAT+ Submit a correction requestReprints John Wilkerson Washington Correspondent John writes about the politics of health care, and he is the author of the twice-weekly D.C. Diagnosis newsletter.

You can reach John on Signal at John_Wilkerson.07. Newsletter The latest updates in federal health agencies, research institutes, and U.S. policy Recommended D.C.

Diagnosis July 23, 2026 STAT Plus: What’s in the last-minute flurry of health care bills? D.C. Diagnosis July 21, 2026 STAT Plus: Rare disease drugmakers try to avoid Trump price cuts Advertisement D.C.

Diagnosis July 9, 2026 STAT Plus: FDA finalists under review D.C. Diagnosis July 7, 2026 STAT Plus: The crumbling employer-based health insurance system D.C. Diagnosis July 2, 2026 STAT Plus: What does DeGette’s loss mean for pharma?

Subscriber Picks

source

Reporting by STAT.

read at STAT ↗
423 words · retrieved 6h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 4h agoSix key issues we’re watching at Fauci’s hearingSTAT
  • 6h agoVisa time limits on foreign Ph.D. students and postdocs will harm U.S. science, experts warnSTAT
  • 9h agoSTAT+: GSK lays out plans to cut costs, pursue more late-stage drug trialsSTAT
  • 9h agoSTAT+: FDA staff reiterate concerns about Replimune skin cancer treatmentSTAT
  • 10h agoSTAT+: Pharmalittle: We’re reading about FDA views on a Duchenne drug, GSK cost savings, and moreSTAT